Karen Read's second murder trial is headed into its first weekend without a fully seated jury after the court spent days vetting dozens of candidates, many of whom were already aware of the high ...

The jury for Karen Read’s trial added four new members on Thursday, bringing the total to 10 after one juror selected on a previous day dropped out. One of the four people selected for the jury ...

STAMFORD — A Bridgeport man likely is headed to trial after rejecting two state offers Monday in the 2010 Norwalk slaying of Karl "K-Dot” Savage. David McBride, 39, charged with murder in ...

The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted ... lifted in 2022 after an investigation ...

A 27-year-old woman is currently on trial after she reportedly assaulted a middle-aged Jewish woman after a lecture on antisemitism in Hamburg, Germany, local media reported on Tuesday.

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

The European Medicines Agency has temporarily suspended enrollment and dosing in a Phase II trial of Sarepta Therapeutics' (Nasdaq: SRPT) gene therapy, Elevidys (delandistrogene moxeparvovec-rokl), ...

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access.

(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is ...